ENABLING PUBLIC HEALTH SUPPLY CHAIN TRANSFORMATION IN SOUTHERN AFRICA
ARC is improving the capability of ministries of health in Southern Africa to achieve their supply chain strategies sustainably to reach their national health objectives.
LEADING EXAMPLES OF ARC’S WORK IN SOUTHERN AFRICA WITH THEIR OUTCOMES
Centralised Chronic Medicines Distribution and Delivery (CCMDD): ARC identified a strategic resource to develop the CCMDD business case for sustainability and upscaling nationally and replicate this differentiated service delivery concept in other countries.
Visibility and Analytics Network (VAN): Building the institutional capability of the National Department of Health (NDoH) to improve the visibility of its supply chain and its analytical competency to mitigate stock-outs. ARC is advising the NDoH on the change management strategy for the Strategy to Improve Medicine Availability (SIMA) and formulating plans for a comprehensive approach to
communicate and drive adoption of change at national and provincial levels.
TLD (Dolutegravir) transition: The United States Agency for International Development (USAID) and The President’s Emergency Plan for AIDS Relief (PEPFAR) engaged ARC to support the transition to a new HIV drug regimen.
Home delivery strategy and scale-up: Providing supply chain, clinical, and business case/impact evaluation expertise for patient-centred self-management support and related services through home delivery, primarily to patients with chronic diseases.
Outsourced distribution business case with Global Financing Facility (GFF): Developing a detailed business case and investment planning project to support the Ministry of Health, Central de Medicamentos e Artigos Médicos (CMAM), to advocate for investment in necessary infrastructure.
Namibia planning project: Growing in-house capacity in health commodity forecasting and supply planning through the identification, recruitment, placement, and management of supply chain technical resources to facilitate a shift to self-reliance by building in-house capacity.